BridgeBio Oncology Therapeutics, Inc. Cash Equivalents, at Carrying Value
BridgeBio Oncology Therapeutics, Inc. (BBOT) had Cash Equivalents, at Carrying Value of $53.60 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-11
- 2026-06-30: Cash Equivalents, at Carrying Value $53.60M.
- 2026-03-31: Cash Equivalents, at Carrying Value $52.20M.
- 2025-12-31: Cash Equivalents, at Carrying Value $373.06M.
- 2024-12-31: Cash Equivalents, at Carrying Value $30.67M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $53.60M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $52.20M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $373.06M 10-Q · filed 2026-08-11 |
| 2024-12-31 | $30.67M POS AM · filed 2026-04-30 |
| 2024-03-31 | $1.84M 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |